Results 21 to 30 of about 206,145 (268)

Scrotal Kaposi's Sarcoma in HIV-negative Patient: A Case Report and Review of the Literature.

Albanian Journal of Trauma and Emergency Surgery, 2023
Background: Kaposi's sarcoma (KS) is an indolent angio-proliferative tumor proliferation with spindle cells originating from endothelial and immune cells infected with human herpes virus type 8. (HHV-8: also known as Kaposi sarcoma herpes virus [KSHV]).
Teona Bushati, Leart Berdica, Albina Ndoja, Erion Sukaj, Ilirian Ibrushi, Leon Kaza   +5 more
doaj   +1 more source

Prevalence and predictors of Kaposi’s sarcoma among HIV patients receiving care at a tertiary hospital in Jos, Nigeria

Journal of Global Health Reports, 2021
# Background Kaposi’s sarcoma became prevalent with the appearance of human immune deficiency virus (HIV) in the 1980s. However, the widespread use of the highly active antiretroviral therapy (HAART) reduced its prevalence in communities with good ...
Jonathan C Daboer, Moses P Chingle, Fabian H Puepet, Tyavyar J Akosu, Oche Agbaji   +4 more
doaj   +1 more source

Risk factors for high anti-HHV-8 antibody titers (≥1:51,200) in black, HIV-1 negative South African cancer patients: a case control study [PDF]

, 2003
Background: Infection with human herpesvirus 8 (HHV-8) is the necessary causal agent in the development of Kaposi's sarcoma (KS). Infection with HIV-1, male gender and older age all increase risk for KS.
BM Friedman, C Boshoff, C Boshoff, D Serraino, D Whitby, DH Kedes, Dimitra Bourboulia, EP Zorrilla, F Sitas, F Vitale, Freddy Sitas, G de-The, G de-The, G Rezza, GR Simpson, H Renwick, J Iscovich, J Ziegler, Janet M Wojcicki, JJ Goedert, JL Ziegler, JL Ziegler, KA Staskus, L Rainbow, Lara Stein, LD Baker, M Dedicoat, Margaret I Urban, Martin Hale, Moosa Patel, P Cook-Mozaffari, P Kellam, Paul Ruff, PS Moore, R Greenblatt, R Newton, R Newton, R Tedeschi, Ranjan Sur, RJ Biggar, Rob Newton, RP Stowe, S Lemeshow, S Plancoulaine, SJ Gao, STATA, Statistics South Africa, TH Bothwell, TH Bothwell, VR Gordeuk, Y Chang, Z Grossman   +51 more
core   +2 more sources

Kaposi’s Sarcoma-Associated Herpesvirus, the Etiological Agent of All Epidemiological Forms of Kaposi’s Sarcoma

Cancers, 2021
Simple Summary Kaposi’s sarcoma-associated herpesvirus (KSHV) is one of the seven oncogenic viruses currently recognized by the International Agency for Research on Cancer.
A. Jary, M. Veyri, Adélie Gothland, V. Leducq, V. Calvez, A. Marcelin   +5 more
semanticscholar   +1 more source

Classic Kaposi's sarcoma treated with elastic stockings and outpatient follow-up of a 90-year-old patient [PDF]

Anais Brasileiros de Dermatologia, 2013
Kaposi's sarcoma is a multifactorial angioproliferative disorder. The herpes virus 8 human contributes to its pathogenesis, but it is uncertain whether these lesions are only reactive hyperplasia to the virus or neoplasia.
Flavia Trevisan, Paulo Rowilson Cunha, Clovis Antonio Lopes Pinto, Celia Antonia Xavier de Moraes Alves   +3 more
doaj   +1 more source

Targeting Kaposi’s sarcoma associated herpesvirus encoded protease (ORF17) by a lysophosphatidic acid molecule for treating KSHV associated diseases

Frontiers in Cell and Developmental Biology, 2023
Kaposi’s sarcoma associated herpesvirus (KSHV) is causative agent of Kaposi’s sarcoma, Multicentric Castleman Disease and Pleural effusion lymphoma. KSHV-encoded ORF17 encodes a protease which cleaves -Ala-Ala-, -Ala-Ser- or -Ala-Thr-bonds.
Misbahuddin M Rafeeq, Alaa Hamed Habib, Alaa F. Nahhas, Najat Binothman, Majidah Aljadani, Jawaher Almulhim, Ziaullah M Sain, Mohammad Zubair Alam, Mohammad Zubair Alam, Norah A Alturki, Qamre Alam, Manish Manish, Rajnish Kumar Singh   +12 more
doaj   +1 more source

Kaposi's sarcoma in an HIV-positive person successfully treated with paclitaxel [PDF]

, 2009
Epidemic Kaposi's sarcoma is one of the malignant neoplasms, which can develop in HIV-infected patients. Although the prevalence of HIV infection is reported to be high in Asian countries, Kaposi's sarcoma is rarely reported. We report a case of Kaposi's
Dongre, Atul, Montaldo, Chiara
core   +1 more source

A case report of the rapid dissemination of Kaposi’s sarcoma in a patient with HIV

African Journal of Primary Health Care & Family Medicine, 2013
Introduction: Kaposi’s sarcoma is the most common HIV-associated neoplastic disease. In most cases it starts on the skin and later spreads to other visceral organs.
Indiran Govender, Mogakgomo H. Motswaledi, Langalibalele H. Mabuza   +2 more
doaj   +1 more source

Consensus of the Brazilian Society of Infectious Diseases and Brazilian Society of Clinical Oncology on the management and treatment of Kaposi's sarcoma

Brazilian Journal of Infectious Diseases, 2014
Kaposi's sarcoma is a multifocal vascular lesion of low-grade potential that is most often present in mucocutaneous sites and usually also affects lymph nodes and visceral organs.
Érico Arruda, Alexandre Andrade dos Anjos Jacome, Ana Luiza de Castro Conde Toscano, Anderson Arantes Silvestrini, André Santa Bárbara Rêgo, Evanius Garcia Wiermann, Geraldo Felicio da Cunha, Jr., Heloisa Ramos Lacerda de Melo, Karen Mirna Loro Morejón, Luciano Zubaran Goldani, Luiz Carlos Pereira, Jr., Mariliza Henrique Silva, Mauro Sergio Treistman, Mônica Cristina Toledo Pereira, Patricia Maria Bezerra Xavier Romero, Rafael Aron Schmerling, Rodrigo Antonio Vieira Guedes, Veridiana Pires de Camargo   +17 more
doaj   +1 more source

Fatal outcome in classic Kaposi's sarcoma [PDF]

, 2010
First described in 1872, Kaposi's sarcoma is defined as a rare multifocal tumor that originates in the endothelial cells and presents with cutaneous and extracutaneous manifestations. The classic form is most common in elderly men and progression is slow.
Almeida, Fernando Augusto de, Enokihara, Mílvia M. S. S., Ohe, Eugênia Maria Damásio N., Padilha, Maria Helena V. de Q., Porro, Adriana Maria   +4 more
core   +3 more sources